FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/19/2023
Back to search
Official data from USPTO
CIMEIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CIMEIO
ST13
US500000079315651Class
5, 42, 44
Filing
79315651
Registration
6914827
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/19/2023
Trademark type
Word
Nice classes
5, 42, 44
Filing date
04/27/2021
Registration date
12/06/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2022
Last transaction
12/06/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
BELL, MARLENE D
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CIMEIO THERAPEUTICS AG
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for gene and cell therapy not for use in connection with dental products or services
Class 42
Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development servicesall in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapynone of the foregoing for use in connection with dental-related products and services
Class 44
GeneT cellB cell and stem cell therapy services; consultant services in the fields of geneT cellB cell and stem cell therapynone of the foregoing for use in connection with dental-related products and services
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/23/2023
FIMP
FINAL DISPOSITION PROCESSED
03/23/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2022
GPNX
NOTIFICATION PROCESSED BY IB
10/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2022
PUBO
PUBLISHED FOR OPPOSITION
09/20/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2022
RFNT
REFUSAL PROCESSED BY IB
02/14/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/25/2022
RFRR
REFUSAL PROCESSED BY MPU
01/25/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/04/2022
CNRT
NON-FINAL ACTION WRITTEN
01/03/2022
DOCK
ASSIGNED TO EXAMINER
12/26/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/23/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens CIMEIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.